Business View Magazine | February 2019

339 the government will move, and what the backlogs are, and what their position on the solid pills will be.We just knowwe’re going to present a scientifi- cally-proven, better delivery system than what ex- ists out there and hope to get approval in the first quarter of 2019-at least for the CBD-XR tablets.” Goldstein: “Once we get our plant built out in Cobourg,we’ll be providing a lot of jobs. It will be a 6,000- sq.-ft. facility,where we’ll produce millions of tablets a day.We’re co-locating with licensed producer FSD Pharma in the old Cool Whip build- ing,which has everything we need in a pharma environment, a GMP environment, and an EGMP environment, so we can manufacture, and distrib- ute globally, out of the one facility.” BVM: What do you see ahead for the cannabis industry in Canada and what are your goals for Canntab? Goldstein: “In five years, I think Canada will have been one of the keys in global acceptance.We’ve started what I think is a cannabis tsunami.The more clinical trials and proof people get that this is real medication, you’re looking at the acceptance of worldwide cannabis use in a positive, healthy way.Today, 70, 80, and 90-year-olds are the fastest growing demographic for medicinal cannabis use; many are using it for the first time. People have pain, arthritis, trouble sleeping–there’s a massive market and any adult is a potential patient, or cli- ent. “Having to draw the level of oil with a dropper to the proper dose level, especially for seniors, can be very cumbersome.Whereas, a tablet is a tablet, like aspirin–the same size and just as easy to take.We want to be the de facto standard going forward, and hopefully changing the minds of a lot more doctors. Currently, there’s only a minority who will script, a minority who won’t script, and a big chunk in the middle who aren’t sure what to do. But give them a 2.5 mg through to a 10 mg micro-dose of the medication, even in an XR platform, and that’s something I think physicians will start to script.Our partner, Emblem, has salespeople visiting doctors and telling themwhat’s available. So, the medical community will know about our tablets, as we work our way through approval.” Renwick: “According to market surveys, the tablet form is probably the most sophisticated delivery system of cannabis, better than oil-filled caps, and we want to get the word out that we have this great system- a very safe and effective method to use cannabis for many different purposes. It’s a sci- entific, technology-based approach.We are focused on medical,we are focused on helping people, and that way we can provide, not just Canadians but the world,with a truly value-added product.” PREFERREDVENDOR Garfinkle Biderman LLP –www.garfinkle.com